Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: a new biomarker for overall survival of patients with malignant diseases.
Matsueda S, Komatsu N, Kusumoto K, Koga S, Yamada A, Kuromatsu R, Yamada S, Seki R, Yutani S, Shichijo S, Mine T, Fukuda T, Okamura T, Okuda S, Sata M, Honda J, Kaji M, Itoh K, Sasada T.
Matsueda S, et al. Among authors: honda j.
Dev Comp Immunol. 2013 Sep;41(1):68-76. doi: 10.1016/j.dci.2013.04.004. Epub 2013 Apr 11.
Dev Comp Immunol. 2013.
PMID: 23583523